Drug Repurposing for Candidate SARS-CoV-2 Main Protease Inhibitors by a Novel In Silico Method

A new coronavirus associated with human respiratory disease in China

(2020) Fan Wu et al.   NATURE

Therapeutic options for the 2019 novel coronavirus (2019-nCoV)

(2020) Guangdi Li et al.   NATURE REVIEWS DRUG DISCOVERY

Covid-19 associated SIADH; a clue in the times of pandemic!

(2020) Zohaib Yousaf et al.   AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM

A Review of SARS-CoV-2 and the Ongoing Clinical Trials

(2020) Yung-Fang Tu et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

Potential anti-viral activity of approved repurposed drug against main protease of SARS-CoV-2: an in silico based approach

(2020) Saurov Mahanta et al.   JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS

Structure of Mpro from SARS-CoV-2 and discovery of its inhibitors

(2020) Zhenming Jin et al.   NATURE

Crystal structure of SARS-CoV-2 main protease provides a basis for design of improved α-ketoamide inhibitors

(2020) Linlin Zhang et al.   SCIENCE

Potential anti‐SARS‐CoV‐2 drug candidates identified through virtual screening of the ChEMBL database for compounds that target the main coronavirus protease

(2020) Motonori Tsuji   FEBS Open Bio

Use of antiviral drugs to reduce COVID-19 transmission

(2020) Oriol Mitjà et al.   Lancet Global Health

Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection?

(2020) Lei Fang et al.   Lancet Respiratory Medicine

Research and Development on Therapeutic Agents and Vaccines for COVID-19 and Related Human Coronavirus Diseases

(2020) Cynthia Liu et al.   ACS Central Science

Therapeutic potential of ciclesonide inhalation for COVID-19 pneumonia: Report of three cases

(2020) Keisuke Iwabuchi et al.   JOURNAL OF INFECTION AND CHEMOTHERAPY

Virtual screening and repurposing of FDA approved drugs against COVID-19 main protease

(2020) Mahmoud Kandeel et al.   LIFE SCIENCES

A Case of Coronavirus Disease 2019 Treated With Ciclesonide

(2020) Kento Nakajima et al.   MAYO CLINIC PROCEEDINGS

Paromomycin: A potential dual targeted drug effectively inhibits both spike (S1) and main protease of COVID-19

(2020) Asma Tariq et al.   INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES

Genetic associations between genes in the renin-angiotensin-aldosterone system and renal disease: a systematic review and meta-analysis

(2019) Laura Jane Smyth et al.   BMJ Open

DrugBank 5.0: a major update to the DrugBank database for 2018

(2017) David S Wishart et al.   NUCLEIC ACIDS RESEARCH

Ebselen, a Small-Molecule Capsid Inhibitor of HIV-1 Replication

(2016) Suzie Thenin-Houssier et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Optimization of parameters for semiempirical methods VI: more modifications to the NDDO approximations and re-optimization of parameters

(2012) James J. P. Stewart   JOURNAL OF MOLECULAR MODELING

Efficacy and safety of oral tolvaptan therapy in patients with the syndrome of inappropriate antidiuretic hormone secretion

(2011) Joseph G Verbalis et al.   EUROPEAN JOURNAL OF ENDOCRINOLOGY

AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading

(2009) Oleg Trott et al.   JOURNAL OF COMPUTATIONAL CHEMISTRY

Prediction of drug-target interaction networks from the integration of chemical and genomic spaces

(2008) Y. Yamanishi et al.   BIOINFORMATICS